HLA-A*02:01-restricted tumor vessel-specific peptide vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HLA-A*02:01-restricted tumor vessel-specific peptide vaccine, covering 2010-12-17 to 2010-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer [Phase 1, Phase 2]